A nonradioactive method for localization of endothelin receptor mRNA in situ

J Cardiovasc Pharmacol. 1998:31 Suppl 1:S443-6. doi: 10.1097/00005344-199800001-00127.

Abstract

To investigate relationships between the distribution of endothelin (ET) receptor expression and histopathology of heart and blood vessels, we developed a method of nonradioactive in situ hybridization in paraffin sections. Rat mesenteric bed, rat heart, and human uterine artery were fixed in formalin and embedded in paraffin ETA and ETB receptor cDNAs were subcloned into plasmid vectors for synthesis of sense and anti-sense probes. Digoxigenin (DIG)-UTP was incorporated into every twentieth to twenty-fifth nucleotide of the newly transcribed cRNA. mRNA was detected in situ using an anti-DIG alkaline phosphatase antibody and an alkaline phosphatase substrate. In blood vessels, ETA receptor mRNA was localized to the medial smooth muscle layer and ETB receptor mRNA to the endothelial and adventitial layers. Hearts from rats that had undergone coronary artery ligation for induction of CHF showed intense staining for ETB receptor mRNA in the scarred and infarcted zone of the left ventricle. This method provides a suitable alternative to radioisotope-labeled probes for detection of ET receptor mRNA. It allows better preservation of tissues, shorter detection time, and improved morphology for microscopic analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arteries / metabolism
  • Blood Vessels / metabolism
  • Female
  • Humans
  • In Situ Hybridization
  • Mesenteric Veins / metabolism
  • Myocardium / metabolism
  • Polymerase Chain Reaction
  • RNA, Messenger / isolation & purification*
  • Rats
  • Receptor, Endothelin A
  • Receptor, Endothelin B
  • Receptors, Endothelin / biosynthesis*
  • Regional Blood Flow
  • Uterus / blood supply
  • Uterus / metabolism

Substances

  • RNA, Messenger
  • Receptor, Endothelin A
  • Receptor, Endothelin B
  • Receptors, Endothelin